Anticoagulant Therapy Is Associated With Decreased Long-Term Mortality in Splenic Infarction Patients: A Multicenter Study

Background: Patients with splenic infarction (SI) are associated with a prothrombotic state and are vulnerable to subsequent thromboembolic complications. However, due to its rarity, there is no established treatment modality in this population. We aimed to examine the effect of anticoagulant therap...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chieh-Ching Yen, Chih-Kai Wang, Chung-Hsien Chaou, Shou-Yen Chen, Jhe-Ping Lin, Chip-Jin Ng
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/e7938cacde6846ebbc259a36b63af3b9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e7938cacde6846ebbc259a36b63af3b9
record_format dspace
spelling oai:doaj.org-article:e7938cacde6846ebbc259a36b63af3b92021-12-01T12:50:15ZAnticoagulant Therapy Is Associated With Decreased Long-Term Mortality in Splenic Infarction Patients: A Multicenter Study2296-858X10.3389/fmed.2021.778198https://doaj.org/article/e7938cacde6846ebbc259a36b63af3b92021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fmed.2021.778198/fullhttps://doaj.org/toc/2296-858XBackground: Patients with splenic infarction (SI) are associated with a prothrombotic state and are vulnerable to subsequent thromboembolic complications. However, due to its rarity, there is no established treatment modality in this population. We aimed to examine the effect of anticoagulant therapy in SI patients.Methods: We performed a multicenter retrospective cohort study of 86 SI patients. Patients were categorized as anticoagulant users and anticoagulant non-users. The associations between anticoagulant therapy, all-cause mortality, thromboembolic events and bleeding events were evaluated.Results: Forty-five patients (52.3%) received anticoagulant therapy during the follow-up periods. The all-cause mortality rate was 6.86 per 100 patient-years. Anticoagulant therapy was associated with 94% improved survival (HR = 0.06; Cl 0.007–0.48; p = 0.008), while the risk factors for all-cause mortality were prior stroke (HR = 13.15; Cl 2.39–72.27; p = 0.003) and liver cirrhosis (HR = 8.71; Cl 1.29–59.01; p = 0.027). Patients with anticoagulant therapy had a higher event-free survival curve for thromboembolic complications (p = 0.03) but did not achieve a significant difference after adjustment using the Cox regression model as a time-dependent covariate (HR = 0.57; Cl 0.13–2.45; p = 0.446). There was no significant difference in the risk of bleeding events between the groups (p = 0.728).Conclusions: Anticoagulant therapy in patients with SI was associated with better survival and was not related to an increased bleeding risk.Chieh-Ching YenChieh-Ching YenChih-Kai WangChih-Kai WangChung-Hsien ChaouChung-Hsien ChaouChung-Hsien ChaouShou-Yen ChenShou-Yen ChenShou-Yen ChenJhe-Ping LinJhe-Ping LinChip-Jin NgChip-Jin NgFrontiers Media S.A.articleanticoagulantsplenic infarctionmortalityoutcometreatmentMedicine (General)R5-920ENFrontiers in Medicine, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic anticoagulant
splenic infarction
mortality
outcome
treatment
Medicine (General)
R5-920
spellingShingle anticoagulant
splenic infarction
mortality
outcome
treatment
Medicine (General)
R5-920
Chieh-Ching Yen
Chieh-Ching Yen
Chih-Kai Wang
Chih-Kai Wang
Chung-Hsien Chaou
Chung-Hsien Chaou
Chung-Hsien Chaou
Shou-Yen Chen
Shou-Yen Chen
Shou-Yen Chen
Jhe-Ping Lin
Jhe-Ping Lin
Chip-Jin Ng
Chip-Jin Ng
Anticoagulant Therapy Is Associated With Decreased Long-Term Mortality in Splenic Infarction Patients: A Multicenter Study
description Background: Patients with splenic infarction (SI) are associated with a prothrombotic state and are vulnerable to subsequent thromboembolic complications. However, due to its rarity, there is no established treatment modality in this population. We aimed to examine the effect of anticoagulant therapy in SI patients.Methods: We performed a multicenter retrospective cohort study of 86 SI patients. Patients were categorized as anticoagulant users and anticoagulant non-users. The associations between anticoagulant therapy, all-cause mortality, thromboembolic events and bleeding events were evaluated.Results: Forty-five patients (52.3%) received anticoagulant therapy during the follow-up periods. The all-cause mortality rate was 6.86 per 100 patient-years. Anticoagulant therapy was associated with 94% improved survival (HR = 0.06; Cl 0.007–0.48; p = 0.008), while the risk factors for all-cause mortality were prior stroke (HR = 13.15; Cl 2.39–72.27; p = 0.003) and liver cirrhosis (HR = 8.71; Cl 1.29–59.01; p = 0.027). Patients with anticoagulant therapy had a higher event-free survival curve for thromboembolic complications (p = 0.03) but did not achieve a significant difference after adjustment using the Cox regression model as a time-dependent covariate (HR = 0.57; Cl 0.13–2.45; p = 0.446). There was no significant difference in the risk of bleeding events between the groups (p = 0.728).Conclusions: Anticoagulant therapy in patients with SI was associated with better survival and was not related to an increased bleeding risk.
format article
author Chieh-Ching Yen
Chieh-Ching Yen
Chih-Kai Wang
Chih-Kai Wang
Chung-Hsien Chaou
Chung-Hsien Chaou
Chung-Hsien Chaou
Shou-Yen Chen
Shou-Yen Chen
Shou-Yen Chen
Jhe-Ping Lin
Jhe-Ping Lin
Chip-Jin Ng
Chip-Jin Ng
author_facet Chieh-Ching Yen
Chieh-Ching Yen
Chih-Kai Wang
Chih-Kai Wang
Chung-Hsien Chaou
Chung-Hsien Chaou
Chung-Hsien Chaou
Shou-Yen Chen
Shou-Yen Chen
Shou-Yen Chen
Jhe-Ping Lin
Jhe-Ping Lin
Chip-Jin Ng
Chip-Jin Ng
author_sort Chieh-Ching Yen
title Anticoagulant Therapy Is Associated With Decreased Long-Term Mortality in Splenic Infarction Patients: A Multicenter Study
title_short Anticoagulant Therapy Is Associated With Decreased Long-Term Mortality in Splenic Infarction Patients: A Multicenter Study
title_full Anticoagulant Therapy Is Associated With Decreased Long-Term Mortality in Splenic Infarction Patients: A Multicenter Study
title_fullStr Anticoagulant Therapy Is Associated With Decreased Long-Term Mortality in Splenic Infarction Patients: A Multicenter Study
title_full_unstemmed Anticoagulant Therapy Is Associated With Decreased Long-Term Mortality in Splenic Infarction Patients: A Multicenter Study
title_sort anticoagulant therapy is associated with decreased long-term mortality in splenic infarction patients: a multicenter study
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/e7938cacde6846ebbc259a36b63af3b9
work_keys_str_mv AT chiehchingyen anticoagulanttherapyisassociatedwithdecreasedlongtermmortalityinsplenicinfarctionpatientsamulticenterstudy
AT chiehchingyen anticoagulanttherapyisassociatedwithdecreasedlongtermmortalityinsplenicinfarctionpatientsamulticenterstudy
AT chihkaiwang anticoagulanttherapyisassociatedwithdecreasedlongtermmortalityinsplenicinfarctionpatientsamulticenterstudy
AT chihkaiwang anticoagulanttherapyisassociatedwithdecreasedlongtermmortalityinsplenicinfarctionpatientsamulticenterstudy
AT chunghsienchaou anticoagulanttherapyisassociatedwithdecreasedlongtermmortalityinsplenicinfarctionpatientsamulticenterstudy
AT chunghsienchaou anticoagulanttherapyisassociatedwithdecreasedlongtermmortalityinsplenicinfarctionpatientsamulticenterstudy
AT chunghsienchaou anticoagulanttherapyisassociatedwithdecreasedlongtermmortalityinsplenicinfarctionpatientsamulticenterstudy
AT shouyenchen anticoagulanttherapyisassociatedwithdecreasedlongtermmortalityinsplenicinfarctionpatientsamulticenterstudy
AT shouyenchen anticoagulanttherapyisassociatedwithdecreasedlongtermmortalityinsplenicinfarctionpatientsamulticenterstudy
AT shouyenchen anticoagulanttherapyisassociatedwithdecreasedlongtermmortalityinsplenicinfarctionpatientsamulticenterstudy
AT jhepinglin anticoagulanttherapyisassociatedwithdecreasedlongtermmortalityinsplenicinfarctionpatientsamulticenterstudy
AT jhepinglin anticoagulanttherapyisassociatedwithdecreasedlongtermmortalityinsplenicinfarctionpatientsamulticenterstudy
AT chipjinng anticoagulanttherapyisassociatedwithdecreasedlongtermmortalityinsplenicinfarctionpatientsamulticenterstudy
AT chipjinng anticoagulanttherapyisassociatedwithdecreasedlongtermmortalityinsplenicinfarctionpatientsamulticenterstudy
_version_ 1718405207732256768